NCT02349815已完成不适用
Pharmacoepidemiological Study (Drug Utilization Study) of JAYDESS Use in Routine Clinical Practice in Sweden
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- Bayer
- 入组人数
- 10,000
- 试验地点
- 1
- 主要终点
- Indication for use
研究概览
简要总结
- To describe characteristics (demographic, clinical, social) of first time users of Jaydess
- To estimate the duration of use of Jaydess
- To study switching patterns, e.g. what are the hormonal contraceptive methods used before and what are the methods after discontinuing Jaydess
- To study off-label use of Jaydess
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 64 Years（Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Swedish women who were dispensed a JAYDESS from a Swedish Pharmacy anytime 2014-2017
排除标准
- •No exclusion criteria
研究组 & 干预措施
Group 1
Women prescribed JAYDESS in Sweden
干预措施: Levonorgestrel (Jaydess, Skyla, BAY86-5028) (Drug)
结局指标
主要结局
Indication for use
时间窗: At insertion
Duration of use of JAYDESS
时间窗: Up to 6 years
次要结局
- Age at insertion and removal(Up to 6 years)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Extended Drug Utilization Study Among Patients Exposed to Ticagrelor, Clopidogrel and PrasugrelBleeding ,Arrhythmias, Heart Failure, Acute Renal Failure, Acute Liver Failure, Dyspnoea, GoutNCT01276275AstraZeneca7,200
已完成
不适用
Descriptive Pharmacoepidemiological Study of Patients Treated With IressaLung CancerNCT01448187AstraZeneca361
已完成
1 期
A Study of Olaratumab in Soft Tissue SarcomaSarcoma, Soft TissueNCT01185964Eli Lilly and Company148
已完成
不适用
Drug Use Study of Febuxostat After Recent Changes in the Prescribing InformationGoutCardiovascular DiseasesNCT04853160Takeda24,046
已完成
1 期
A Study of JNJ-70033093 (BMS-986177) in Healthy Chinese Adult ParticipantsHealthyNCT04569695Janssen Research & Development, LLC40